MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oz, M.
Right arrow Articles by Morad, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oz, M.
Right arrow Articles by Morad, M.

Vol. 54, Issue 6, 1106-1112, December 1998

Functional Coupling of Human L-Type Ca2+ Channels and Angiotensin AT1A Receptors Coexpressed in Xenopus laevis Oocytes: Involvement of the Carboxyl-Terminal Ca2+ Sensors

Murat Oz, Michael T. Melia, Nikolai M. Soldatov, Darrell R. Abernethy, and Martin Morad

Georgetown University Medical Center, Department of Pharmacology, Washington, DC 20007

    Summary
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References

A human recombinant L-type Ca2+ channel (alpha 1C,77) was coexpressed with the rat angiotensin AT1A receptor in Xenopus laevis oocytes. In oocytes expressing only alpha 1C,77 channels, application of human angiotensin II (1-10 µM) did not affect the amplitude or kinetics of Ba2+ currents (IBa). In sharp contrast, in oocytes coexpressing alpha 1C,77 channels and AT1A receptors, application of 1 nM to 1 µM angiotensin gradually and reversibly inhibited IBa, without significantly changing its kinetics. The inhibitory effect of angiotensin on IBa was abolished in oocytes that had been preincubated with losartan (an AT1A receptor antagonist) or thapsigargin or injected with 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetate, pertussis toxin, guanosine-5'-O-(2-thio)diphosphate, or heparin, suggesting that the recombinant alpha 1C channels were regulated by angiotensin through G protein-coupled AT1A receptors via activation of the inositol trisphosphate-dependent intracellular Ca2+ release pathway. Consistent with this hypothesis, no cross-signaling occurred between the AT1A receptor and a splice variant of alpha 1C lacking Ca2+ sensors (alpha 1C,86). The data suggest that the regulation of recombinant L-type Ca2+ channels by angiotensin is mediated by inositol trisphosphate-induced intracellular Ca2+ release and occurs at the molecular motif responsible for the Ca2+-induced inactivation of the channels.

    Introduction
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References

Voltage-gated Ca2+ channels are a major route for Ca2+ entry into cells in response to stimulation by hormones, neurotransmitters, or drugs. The resulting rise in cytoplasmic free Ca2+ triggers a cascade of intracellular signaling events, which underlie a variety of cellular responses, ranging from contraction and secretion to growth and mitogenesis. Therefore, identification of the molecular basis for functional coupling between Ca2+ channels and hormone or neurotransmitter receptors may provide critical information on cellular signaling mechanisms.

The cardiac L-type Ca2+ channel is composed of the pore-forming alpha 1C and auxiliary beta  and alpha 2/delta subunits (Catterall, 1995). In an artificial expression system, the alpha 1Cbeta alpha 2/delta complex is sufficient to give rise to Ca2+ channels exhibiting all of the major electrophysiological properties observed in vivo. However, functional regulation of the recombinant Ca2+ channel remains largely unknown. For example, in cardiac or vascular cells, the alpha 1C channel is modulated by protein kinase A- and protein kinase C-dependent phosphorylation (McDonald et al., 1994). However, when all three recombinant subunits of the channel are coexpressed in Xenopus laevis oocytes or in eukaryotic systems (Chinese hamster ovary or human embryonic kidney cells), their modulation through phosphorylation is either strongly reduced or essentially absent (Bouron et al., 1995; Zong et al., 1995; Shuba et al., 1997), even though the expressed channels display the same voltage dependence, gating kinetics, unitary conductance, and pharmacological properties as the native alpha 1C L-type Ca2+ channels. These findings demonstrate the complexity of molecular signaling involving the alpha 1C Ca2+ channels; this complexity extends to the largely unexplored area of "cross-talk" between recombinant alpha 1C channels and hormone receptors that are coexpressed in X. laevis oocytes.

The coupling of alpha 1C Ca2+ channels with angiotensin II AT1 receptors has attracted much attention. For example, the L-type Ca2+ channel blockers verapamil, diltiazem, and nifedipine have been shown to block angiotensin II-mediated vascular contraction in vivo in humans (Andrawis et al., 1992). Activation of AT1 receptors seems to be associated with both immediate contractile and long term growth responses in vascular smooth muscle and cardiac myocytes (Baker et al., 1992; Sadoshima and Izumo, 1993; Miyata and Haneda, 1994). Supporting the possibility of interactions between the G protein-coupled AT1 receptors (Anand-Srivastava, 1983; Ohya and Spereliakis, 1991) and voltage-activated Ca2+ channels is the regulation of neuronal (Scott and Dolphin, 1987) and cardiac (Yatani et al., 1987) L-type Ca2+ channels by PTX-sensitive or -insensitive G proteins. Similar interactions have been suggested for angiotensin II activation of L-type Ca2+ currents in rat portal vein myocytes (Macrez-Lepretre et al., 1996) and T-type Ca2+ currents in adrenal zona glomerulosa cells (Lu et al., 1996).

In this study, we have used the X. laevis oocyte expression system to study the functional coupling between recombinant rat AT1A receptors and splice variants of recombinant human alpha 1C Ca2+ channels with or without the molecular motif responsible for Ca2+-dependent inactivation of the channel. We show that heterogeneously expressed Ca2+ channels and AT1A receptors are functionally coupled via the G protein/IP3-mediated Ca2+ signaling cascade. Additionally, we report that the molecular locus for the angiotensin-induced modulation of the alpha 1C Ca2+ channel is independent of permeation of Ca2+ through the pore and is confined to the carboxyl-terminal cytoplasmic motif (positions 1572-1651), which contains multiple Ca2+ sensors of the channel.

    Materials and Methods
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References

Preparation of mRNAs. Template alpha 1C,77 (Soldatov et al., 1995) and alpha 1C,86 (Soldatov et al., 1997) cDNAs were linearized by digestion with BamHI. Capped transcripts were synthesized in vitro with T7 RNA polymerase, using the mRNA cap kit (Stratagene, La Jolla, CA). mRNAs were dissolved in water (0.5 µg/µl). Rat angiotensin AT1A receptor (Murphy et al., 1991) transcripts were kindly provided by Kathryn Sandberg (Georgetown University).

Oocyte preparation and injection. Mature female X. laevis frogs were purchased from Xenopus I (Ann Arbor, MI). Clusters of oocytes were defolliculated by shaking for 2 hr at room temperature in 25 ml of medium containing 82.5 mM NaCl, 2 mM KCl, 1 mM MgCl2, 5 mM HEPES, pH 7.5 (adjusted with NaOH), and 0.2% collagenase A (Boehringer Mannheim, Indianapolis, IN). Oocytes were injected with 50-100 nl of alpha 1C,77 or alpha 1C,86 mRNA premixed with mRNAs coding for auxiliary beta 1 (Ruth et al., 1989) and alpha 2delta subunits (Singer et al., 1991) and the AT1A receptor (in a 1:1:1:0.05 molar ratio). Injected oocytes were incubated at 18° in sterile Barth's medium supplemented with 10,000 units/liter penicillin, 10 mg/liter streptomycin, 50 mg/liter gentamicin, and 0.5 mM theophylline (all from Sigma Chemical Co., St. Louis, MO).

Electrophysiological measurements. Whole-cell ion currents were recorded at room temperature (20-22°) by a two-electrode, voltage-clamp method, as previously described (Soldatov et al., 1998). Current traces were elicited at 30-sec intervals by 1-sec (current-voltage relationships) or 250-msec test pulses to +20 mV, from a holding potential of -90 mV. The Ba2+ extracellular (bath) solution contained 50 mM NaOH, 1 mM KOH, 10 mM HEPES, and 40 mM Ba(OH)2 (pH adjusted to 7.4 with methanesulfonic acid). Voltage-clamped oocytes were continuously perfused with control experimental solutions at the rate of ~10 ml/min (bath volume, ~150 µl). Human angiotensin II (Sigma) was applied extracellularly. In some experiments, oocytes were injected with 50 nl of PTX (5 µg/ml), 10 mM GDPbeta S, 94 mM Cs4BAPTA (pH 7.4), or 10 µM heparin (molecular weight, ~3000; Sigma) approximately 1 hr before the experiment. In other experiments, oocytes were incubated at 18° overnight in Ca2+-free Barth's solution containing 10 nM thapsigargin (RBI, Natick, MA), to deplete their intracellular Ca2+ stores. Results are shown as mean ± standard error. IBa, determined in the presence of 5 µM (±)-PN200-110 to block the L-type current, did not exceed 3-5% of the total current.

    Results
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References

Coexpression of the alpha 1C,77 channel with the AT1A receptor allows regulation of Ca2+ channels by angiotensin. Coinjection into X. laevis oocytes of cRNAs coding for the conventional alpha 1C,77 channel and auxiliary beta 1 and alpha 2delta subunits gave rise to the expression of well defined, slowly inactivating currents through Ca2+ channels 2-3 days after the injection of cRNAs (Soldatov et al., 1995). With Ba2+ as a charge carrier, step depolarization to +20 mV from a holding potential of -90 mV activated a slowly inactivating, L-type IBa (mean amplitude, -1.64 ± 0.33 µA, n = 9). Application of 0.5-10 µM angiotensin to oocytes expressing only alpha 1C,77 Ca2+ channels produced little or no change in the magnitude or the kinetics of the current, at all voltages examined (Fig. 1, A and C; Table 1).


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 1.   Effect of angiotensin on Ca2+ currents. A, Representative traces of IBa through alpha 1C,77 channels, elicited by stepwise depolarization to +20 mV from a holding potential of -90 mV, before (bullet ) and 4 min after (open circle ) application of 1 µM angiotensin. B, Traces of IBa through alpha 1C,77 channels coexpressed with AT1A receptors, recorded before (bullet ) and 1.5, 2, and 3 min after application of 1 µM angiotensin. C, Time dependence and reversibility of the angiotensin effect on IBa through alpha 1C,77 channels expressed alone (black-square) or coexpressed with AT1A receptors (). IBa amplitudes were measured in response to 250-msec test pulses to +20 mV, applied at 30-sec intervals, and were normalized to maximal IBa in the absence of angiotensin. Arrows, times of application of bath solutions containing the indicated concentrations of angiotensin. D, Current-voltage relationships for IBa through alpha 1C,77 channels coexpressed with AT1A receptors, before treatment (bullet ), 5 min after treatment with 1 µM angiotensin (open circle ), and after a 10-min perfusion with bath medium (), obtained using the same oocyte as in B and C (). Experiments were performed at room temperature (~21°).

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1
Inhibition of IBa in X. laevis oocytes by angiotensin depends on the expression of the alpha 1C subunit of Ca2+ channel and the AT1A receptor

Oocytes were injected with mRNAs coding for auxiliary beta 1 and alpha 2delta subunits of the Ca2+ channel, mixed with the indicated mRNAs. IBa traces were elicited by 250-msec test pulses to +20 mV from a holding voltage of -90 mV. Average amplitudes of IBa were measured before (control) and 5 min after application of 0.5-10 µM angiotensin. In some experiments, oocytes were injected 30-60 min before measurements with 50 nl of 5 µg/ml PTX, 10 mM GDPbeta S, 10 µM heparin, or 94 mM Cs4BAPTA or were incubated overnight with 10 nM thapsigargin.

In sharp contrast, in oocytes coexpressing the human alpha 1C,77 channel and rat AT1A receptor (Murphy et al., 1991), angiotensin (0.1-1 µM) inhibited IBa by ~54% (n = 12), in a time- and concentration-dependent manner (Table 1). The suppressive effect of angiotensin developed within 3-4 min of the hormone exposure, but the effect slowly (20-30 min) reversed even in the presence of the hormone. Fig. 1C shows that 57.6% inhibition of IBa by 1 µM angiotensin reversed spontaneously and washout of the hormone did not accelerate the recovery of the current (Fig. 2). In the presence of angiotensin, IBa recovered by 90.2 ± 4.0% (n = 7) within 20-30 min. The voltage dependence of IBa at the peak of the hormone effect was often shifted by approximately +10 mV (Fig. 1D). These results suggest that the time course of the hormone effect is not critically dependent on the continued presence of the hormone.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 2.   Failure of angiotensin to suppress IBa through alpha 1C,86 channels coexpressed with AT1A receptors. A, Representative traces of IBa elicited by stepwise depolarization to +20 mV, from a holding potential of -90 mV, recorded before (bullet ) and 5 min after (open circle ) application of 1 µM angiotensin. B, Time dependence of the effect of 1 µM angiotensin added to the external Ba2+ solution (arrow) on IBa through the alpha 1C,86 channels. C, Averaged current-voltage relationships (n = 3) determined before (bullet ) and 5 min after (open circle ) application of 1 µM angiotensin. In B and C, the amplitudes of IBa were normalized to maximal IBa in the absence of angiotensin.

Fig. 3A illustrates the concentration dependence of the angiotensin effect on alpha 1C,77 channels. Under our experimental conditions, the maximal inhibitory effect (~60% suppression) was reached with 1 µM angiotensin. In none of the cells tested (n = 12) did the inhibitory effect on IBa exceed 60%. The estimated IC50 value for angiotensin was 33 ± 8 nM (n = 4), with a Hill coefficient of approximately 0.85. 


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 3.   A, Concentration-response relationship for the angiotensin effect. Angiotensin, at the indicated concentrations, was applied to an oocyte coexpressing alpha 1C,77 channels and AT1A receptors. IBa was measured at +20 mV, after 5 min of equilibration. The averaged concentration dependence clearly shows saturation of the effect at 1 µM angiotensin. The curve was normalized to the maximal effect and then fit by the function I = 1/{1 + (IC50/[Ang])n}, where I is the normalized IBa amplitude, IC50 is the concentration of angiotensin producing 50% inhibition of IBa, [Ang] is the concentration of angiotensin in the bath solution, and n is the Hill coefficient. The regression coefficient was 0.992. Values are means ± standard errors of four oocytes. B, Time course of the effect of 1 µM losartan and/or 1 µM angiotensin on peak IBa evoked by stepwise depolarization to +20 mV from a holding potential of -90 mV, in an oocyte expressing alpha 1C,77 channels and AT1A receptors. Horizontal bars, times at which losartan and/or angiotensin was applied to the oocyte. Inset, traces of IBa recorded at 1 (bullet ), 4 (), 8 (black-square), and 15 (open circle ) min in this experiment.

Angiotensin failed to suppress the Ca2+ channels in the presence of the reversible AT1A receptor antagonist losartan. Fig. 3B shows that 1 µM losartan had no effect by itself on IBa in an oocyte coexpressing AT1A receptors and alpha 1C channels but completely blocked the angiotensin effect. Replacement of losartan-containing solution with one containing 1 µM angiotensin, however, produced up to 40% (n = 3) inhibition of IBa. The time course of the inhibition of IBa was slower than in control experiments (Figs. 1C, 4, and 5), which might have been partly caused by the slow dissociation of losartan from the AT1A receptor sites. Taken together, these data suggest that the suppression of IBa through alpha 1C,77 channels by angiotensin is mediated through the direct interaction of angiotensin with AT1A receptors.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 4.   Time course of the development of angiotensin effects on IBa and ICl(Ca) in oocytes coexpressing AT1A receptors and alpha 1C,77 channels. Lower, time dependence of the effect of angiotensin on the holding current, ICl(Ca) (black-square), measured at -90 mV and on IBa () measured at +20 mV. Arrow, time when 1 µM angiotensin was applied to the oocyte. Upper, traces of IBa recorded at the times indicated (numbers in lower).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 5.   Dependence of the reversibility of the angiotensin effect on the loading of intracellular Ca2+ stores. Lower, time course of the effect of 1 µM angiotensin applied (arrows 1) to an oocyte bathed in 40 mM Ba2+-containing solution. Test pulses to +20 mV were applied every 30 sec. Arrows 0, washout of angiotensin. The suppressive effect of angiotensin was fully reversed in the oocyte, but washout for 10 min in Ba2+-containing solution did not restore the angiotensin response. Horizontal bar, incubation of the oocyte in normal Barth's solution containing 2 mM Ca2+. Reapplication of angiotensin even after 5 min of incubation in Ca2+-containing Barth's solution restored the angiotensin effect. Upper, traces of IBa recorded at the indicated times.

Angiotensin activates a transient ICl. The rapid application of the hormone in Cl--free solutions was often but not always accompanied by activation of a large, transient, inward current lasting ~2 min. The activation of this inward holding current, measured at -90 mV in Cl--free extracellular solution (Fig. 4, lower), preceded the decrease in IBa. This current had properties similar to those previously identified (Hartzell, 1996; Gomez-Hernandez et al., 1997) for ICl(Ca). During the activation of ICl, IBa often exhibited decreased inactivation kinetics, producing large, slowly deactivating, tail currents (Fig. 4, upper, traces 2 and 3). Interestingly, the angiotensin-induced, transient suppression of IBa outlasted the activation of ICl(Ca) by 2-3 min (Fig. 4), suggesting either different affinities of Ca2+ channels and Ca2+-activated Cl- channels for Ca2+ or differences in the spatial distribution of the two channels with respect to the intracellular Ca2+ pools. Lower affinity of ICl(Ca) for activation by Ca2+, compared with Ca2+-induced inactivation of Ca2+ channels, and variations in the Ca2+ contents of intracellular Ca2+ pools of the oocytes might be partly responsible for the variations in the magnitude of ICl in different oocytes.

The IP3/Ca2+ signaling pathway is involved in channel regulation by angiotensin. Ca2+ stores in X. laevis oocytes are known to be regulated through the activation of IP3-sensitive Ca2+ release channels (Berridge and Irvine, 1989; Putney et al., 1989). These channels are thought to be involved in receptor-mediated Ca2+ signaling, and their activation is known to evoke ICl(Ca) in oocytes (Yao and Parker, 1993; Hartzell, 1996). Consistent with this idea, in oocytes bathed in Barth's solution and expressing only AT1A receptors, a transient (2-3-min) ICl was activated upon rapid application of angiotensin (data not shown). To further characterize the steps in the regulation of recombinant alpha 1C channels by AT1A receptors, when coexpressed in oocytes, we probed the various steps of the IP3-mediated Ca2+ signaling cascade by inhibiting the G proteins, blocking the IP3 receptor, and interfering with the rise in intracellular Ca2+ levels.

Release of intracellular Ca2+ mediates the angiotensin-induced effects. The depletion of intracellular Ca2+ stores by overnight incubation of oocytes with 10 nM thapsigargin (Thastrup et al., 1990) completely abolished the effect of 1 µM angiotensin on IBa (Fig. 6, A and B). No significant difference in the amplitude of IBa in control and thapsigargin-incubated oocytes was observed (Table 1). Similarly, oocytes injected with Ca2+ buffers failed to respond to angiotensin. Fig. 6, C and D, shows data recorded from an oocyte that was injected with 50 nl of 94 mM Cs4BAPTA solution 30 min before measurements of IBa. The data (n = 4) showed that signaling between alpha 1C,77 channels and AT1A receptors in response to 0.1-1 µM angiotensin was completely suppressed.


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 6.   Molecular steps in the modulation of IBa by angiotensin. Two sets of pairs of averaged current-voltage relationships (A, C, and E) and time-dependent relationships for the angiotensin effect (B, D, and F), as well as representative current traces, were recorded before (bullet , black-triangle) and 5 min after (open circle , triangle ) application of 1 µM angiotensin. Arrows, times at which angiotensin (ATII) was applied. A and B, Examination of the role of intracellular Ca2+ release. Oocytes were incubated overnight with 10 nM thapsigargin (A, bullet , open circle , n = 3; B, ) or injected 30-60 min before measurements with 50 nl of 94 mM Cs4BAPTA (A, black-triangle, triangle , n = 6; B, black-square). C and D, Examination of the role of G proteins. Oocytes were injected 30-60 min before measurements with 50 nl of 10 mM GDPbeta S (C, bullet , open circle , n = 4; D, ) or 5 µg/ml PTX (C, black-triangle, triangle , n = 5; D, black-square). E and F, Examination of the involvement of IP3 receptors. Oocytes were injected 30-60 min before measurements with 50 nl of 10 µM heparin (molecular weight, 3000) (E, bullet , open circle , n = 4; F, ). We also show the response of a control oocyte, coexpressing alpha 1C,77 channels and AT1A receptors (E, black-triangle, triangle , n = 6; F, black-square), to angiotensin before the interventions described in A-F.

PTX-sensitive G proteins and IP3 receptors mediate the angiotensin-induced effects. AT1A receptors in mammalian cells are known to be coupled to G proteins (Lu et al., 1996). In X. laevis oocytes coexpressing AT1A receptors and Ca2+ channels, we probed the functional manifestation of G protein coupling. In oocytes that had been preinjected with 50-100 nl of GDPbeta S (10 mM), angiotensin (1 µM) failed to produce significant inhibitory effects on IBa (Fig. 6, C and D; Table 1). Because the effect of angiotensin was also blocked in parallel experiments with microinjection of 50-100 nl of PTX (5 µg/ml) (Fig. 6, C and D; Table 1), the coupling between the recombinant AT1A receptors and alpha 1C,77 Ca2+ channels seemed to be mediated through the activation of endogenous G proteins of the Gi type.

To directly examine the involvement of IP3-sensitive Ca2+ release channels, oocytes coexpressing alpha 1C channels and AT1A receptors were injected with 50 nl of 10 µM heparin (known to block IP3 receptors) (Guillemette et al., 1989) 30-60 min before the experiment. Fig. 6, E and F, shows that, in heparin-injected oocytes, angiotensin failed to produce its Ca2+ channel-suppressive effect on either the current-voltage relationship (Fig. 6E; Table 1) or the time course of IBa (Fig. 6F).

Therefore, it seems that the release of Ca2+ via the IP3 signaling pathway mediates the angiotensin-induced suppressive effect on IBa. We examined whether the effect of the hormone was directly related to the content of intracellular Ca2+ stores. Fig. 5 shows data from an experiment in which, after inhibition and recovery of IBa in the presence of 1 µM angiotensin and a 10-min washout in Ba2+-containing Ringer's solution, the reapplication of 1 µM angiotensin failed to produce any effect on IBa. However, after 5 min of incubation of the oocyte in normal Ca2+-containing Barth's solution, the response of Ca2+ channels to 1 µM angiotensin partially recovered. This finding is consistent with the idea that, during incubation in Barth's solution, IP3-sensitive intracellular Ca2+ stores are replenished with Ca2+ by entry of Ca2+ through depletion-activated Ca2+ channels (Zweifach and Lewis, 1995; Lepple-Wienhues and Cahalan, 1996; Parekh and Penner, 1997) or alpha 1C,77 Ca2+ channels, making it possible for angiotensin to induce Ca2+ release.

A Ca2+-insensitive alpha 1C,86 Ca2+ channel coexpressed with the AT1A receptor is not modulated by angiotensin. To examine a molecular motif possibly involved in angiotensin-mediated modulation of Ca2+ channels, a recently described Ca2+ channel isoform (alpha 1C,86) lacking the Ca2+ sensors responsible for Ca2+-induced modulation (Soldatov et al., 1997) was coexpressed with AT1A receptors in X. laevis oocytes. In contrast to the effect of angiotensin on the alpha 1C,77 channel (Figs. 1, 3, and 4), the alpha 1C,86 channel was insensitive to modulation by angiotensin (Table 1). Fig. 2A demonstrates that neither the amplitude nor the kinetics of IBa were significantly changed in the presence of angiotensin. There was often a 5-15% increase in the amplitude of IBa (Fig. 2B), which resembled the small increase of IBa observed in oocytes expressing alpha 1C,77 without the AT1A receptor (Fig. 1C). Interestingly, the voltage dependence of IBa through alpha 1C,86 channels was also reversibly shifted to more positive potentials in the presence of 1 µM angiotensin (Fig. 2C), in a manner similar to that observed for alpha 1C,77 (Fig. 1D). This shift might be the result of additional screening effects of the released Ca2+ on the plasma membrane cation-binding sites. The absence of angiotensin effects in oocytes coexpressing alpha 1C,86 with AT1A receptors suggests that the Ca2+ sensors of the Ca2+ channel are critical in mediating the suppressive effect of angiotensin on the channel.

    Discussion
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References

Our results show conclusively that, in the oocyte expression system, human recombinant alpha 1C Ca2+ channels can be modulated by angiotensin through AT1A receptors via the G protein-dependent, IP3-activated Ca2+ release system. Inhibition of any of the key steps in the IP3-dependent Ca2+ signaling pathway, including blockade of AT1A receptors (by losartan), G proteins (by GDPbeta S or PTX), or IP3 receptors (by heparin) and depletion of intracellular Ca2+ stores (by thapsigargin or BAPTA), eliminated the suppressive effect of angiotensin on the Ca2+ channels. The hormone-induced transient increase of the intracellular Ca2+ concentration also activated Ca2+-dependent Cl- channels (Hartzell, 1996; Gomez-Hernandez et al., 1997), which was monitored in our experiments as the transient increase in the holding current at -90 mV (Fig. 4). The Ca2+-dependent outward Cl- flux (inward ICl) seems to produce sufficient increases in membrane conductance to cause slowing of the inactivation kinetics of IBa and development of slowly deactivating "tails" (Fig. 4).

It is intriguing to note that, although the hormone suppressed the amplitude of IBa by releasing intracellular Ca2+, the kinetics of the current was not significantly accelerated (Fig. 1B), as might have been expected from a comparison of Ca2+ and Ba2+ current traces recorded in the oocyte expression system (e.g., Fig. 2A in the report by Soldatov et al., 1998). One possible explanation for this result is that pore-permeating Ca2+ and intracellularly released Ca2+ may regulate the alpha 1C channel activity by targeting different molecular sites (Ca2+ sensors) associated with the channel. Similar dual modulation of Ca2+ channel kinetics by intracellular Ca2+ was first observed in dorsal root ganglion neurons (Morad et al., 1988). In that case, photorelease of caged Ca2+ (10-50 µM) strongly suppressed the Na+ current through the channel, without affecting the kinetics of its inactivation. In support of the idea of dual modulation, we recently reported that a segment (positions 1572-1651) of the cytoplasmic carboxyl-terminal tail of alpha 1C,77 contains two separate Ca2+ sensors (molecular determinants for the Ca2+-dependent inactivation of the channel) (Soldatov et al., 1998). The identified Ca2+ sensors may differentially contribute to the Ca2+-induced inactivation of the channel, because they may be selectively targeted by permeating versus cytoplasmic Ca2+ because of their specific locations with respect to the pore. Consistent with this idea, the alpha 1C,86 channel, which lacks Ca2+ sensors in the carboxyl-terminal tail and does not show Ca2+-dependent inactivation, conducts Ca2+ and Ba2+ with comparable kinetics (Soldatov et al., 1997) and is insensitive to angiotensin-mediated increases in intracellular Ca2+ concentrations (Fig. 6; Table 1). Because segment 1572-1651 is the only molecular motif modified in the alpha 1C,86 channel, compared with the alpha 1C,77 channel, we conclude that this locus is largely responsible for the angiotensin-induced modulation of the alpha 1C,77 channel coexpressed with the AT1A receptor. This modulation takes place when Ba2+ is the charge carrier through the channel and is apparently independent of permeation of Ca2+ through the pore.

Our data on the differential modulation of Ca2+ channels by pore-permeating Ca2+ and Ca2+ released in the cytosol might indicate critical steps in cross-signaling between the angiotensin receptor and IP3-gated Ca2+ stores. Such dual control adds to the complexity of the mechanisms of cross-talk between Ca2+ channels and G protein-coupled receptors and may be of fundamental physiological significance, considering that signaling may take place in confined cellular microdomains.

    Acknowledgments

The recombinant angiotensin AT1A receptor cRNA was kindly supplied by Kathryn Sandberg (Georgetown University). We are grateful to F. Hofmann and V. Flockerzi for a gift of beta 1 and alpha 2delta subunit clones.

    Footnotes

Received June 24, 1998; Accepted September 3, 1998

This work was supported in part by a grant-in-aid from the American Heart Association, Nation's Capital Affiliate (to N.M.S.), and National Institutes of Health Grants HL16152 (to M.M.) and AG08226 and GM08386 (to D.R.A.).

Send reprint requests to: Dr. Martin Morad, Georgetown University Medical Center, Department of Pharmacology, 3900 Reservoir Road N.W., Washington, DC 20007. E-mail: moradm{at}gunet.georgetown.edu

    Abbreviations

PTX, pertussis toxin; IP3, inositol trisphosphate; BAPTA, 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetate; GDPbeta S, guanosine-5'-O-(2-thio)diphosphate; ICl(Ca), Ca2+-activated Cl- current; IBa, Ba2+ current; ICl, Cl- current; HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid.

    References
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References


0026-895X/98/061106-07$3.00/0
MOLECULAR PHARMACOLOGY, 54:1106-1112 (1998).
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
M. Oz, K.-H. Yang, M. Dinc, and T. S. Shippenberg
The Endogenous Cannabinoid Anandamide Inhibits Cromakalim-Activated K+ Currents in Follicle-Enclosed Xenopus Oocytes
J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 547 - 554.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Oz, S. N. Jackson, A. S. Woods, M. Morales, and L. Zhang
Additive Effects of Endogenous Cannabinoid Anandamide and Ethanol on {alpha}7-Nicotinic Acetylcholine Receptor-Mediated Responses in Xenopus Oocytes
J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1272 - 1280.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Oz, L. Zhang, A. Ravindran, M. Morales, and C. R. Lupica
Differential Effects of Endogenous and Synthetic Cannabinoids on {alpha}7-Nicotinic Acetylcholine Receptor-Mediated Responses in Xenopus Oocytes
J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 1152 - 1160.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Weiss, T. Doan, K. E. Bernstein, and N. Dascal
Modulation of Cardiac Ca2+ Channel by Gq-activating Neurotransmitters Reconstituted in Xenopus Oocytes
J. Biol. Chem., March 26, 2004; 279(13): 12503 - 12510.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Oz, A. Ravindran, O. Diaz-Ruiz, L. Zhang, and M. Morales
The Endogenous Cannabinoid Anandamide Inhibits {alpha}7 Nicotinic Acetylcholine Receptor-Mediated Responses in Xenopus Oocytes
J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 1003 - 1010.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. R. Abernethy and N. M. Soldatov
Structure-Functional Diversity of Human L-Type Ca2+ Channel: Perspectives for New Pharmacological Targets
J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 724 - 728.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. L. Kamatchi, M. E. Durieux, and C. Lynch III
Differential Sensitivity of Expressed L-Type Calcium Channels and Muscarinic M1 Receptors to Volatile Anesthetics in Xenopus Oocytes
J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 981 - 990.
[Abstract] [Full Text]


Home page
J. Neurophysiol.Home page
D. C. Bell, A. J. Butcher, N. S. Berrow, K. M. Page, P. F. Brust, A. Nesterova, K. A. Stauderman, G. R. Seabrook, B. Nurnberg, and A. C. Dolphin
Biophysical Properties, Pharmacology, and Modulation of Human, Neuronal L-Type ({alpha}1D, CaV1.3) Voltage-Dependent Calcium Currents
J Neurophysiol, February 1, 2001; 85(2): 816 - 827.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oz, M.
Right arrow Articles by Morad, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oz, M.
Right arrow Articles by Morad, M.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics